FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/07/034633 [Registered on: 06/07/2021] Trial Registered Prospectively
Last Modified On: 02/07/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of transversus abdominis plane block in lower segment caesarean section with comparative study of efficacy and safety of bupivacaine and ropivacaine. 
Scientific Title of Study   A comparative study of efficacy and safety of transversus abdominis plane block with bupivacaine and ropivacaine for post-operative analgesia following lower segment caesarean section:A prospective, randomized, controlled, double blind study. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Susheela Choudhary 
Designation  Postgraduate resident 
Affiliation  JLN Medical college Ajmer 
Address  Department of anesthesiology New OT JLN medical college Ajmer

Ajmer
RAJASTHAN
305001
India 
Phone  8058376584  
Fax    
Email  susheelachoudhary2020@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Veena Patodi 
Designation  Senior Professor & Head of Department 
Affiliation  JLN Medical college Ajmer 
Address  Department of anesthesiology New OT JLN medical college Ajmer

Ajmer
RAJASTHAN
305001
India 
Phone  941408276  
Fax    
Email  veenapatodi@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Veena Patodi 
Designation  Senior Professor & Head of Department 
Affiliation  JLN Medical college Ajmer 
Address  Department of anesthesiology New OT JLN medical college Ajmer

Ajmer
RAJASTHAN
305001
India 
Phone  9414008276  
Fax    
Email  veenapatodi@gmail.com  
 
Source of Monetary or Material Support  
JLN MEDICAL COLLEGE AJMER 
 
Primary Sponsor  
Name  JLN Medical college Ajmer 
Address  Department of anaesthesiology, JLN medical college Ajmer, Rajasthan 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Susheela Choudhary  JLN medical college Ajmer  New OT Department of anesthasiology JLN medical college Ajmer Rajasthan
Ajmer
RAJASTHAN 
8058376584

susheelachoudhary2020@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
JLN Medical college Ajmer  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O82||Encounter for cesarean delivery without indication,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  inj Bupivacaine 0.25% in transversus abdominis plane block in spinal anesthesia.  Transversus abdominis plane block using Bupivacaine 0.25% 15ml+15ml bilaterally at petit triangle is given once above iliac creast using anatomical landmark guided tecnique,Block is given after surgery only ONCE to the patient of study. 
Comparator Agent  Inj Ropivacaine 0.25% in transversus abdominis plane block in spinal anesthesia.  Transversus abdominis plane block using Ropivacaine 0.25% 15ml+15ml bilaterally at petit triangle is given once above iliac creast using anatomical landmark guided tecnique,Block is given after surgery only ONCE to the patient of study. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  Pregnant patients between 20years -35 years
Informed consent for participation in study
ASA physical 1& 2
Elective or non-urgent lower segment caesarean section 
 
ExclusionCriteria 
Details  Age less than 20 years and above 35 years
Patients not willing to participate in the study
Any hypersensitivity or contraindication to local anaesthetics
Patient with chronic pain or on long-term analgesics
contraindication to spinal anaesthesia like local infection at the site of lumbar puncture,any bleeding disorders like thrombocytopenia,space occupying lesion of the brain,anatomical disorders of the spine,hypovolemia 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Comparison of number and frequency of post operative analgesia required in both the groups for first 24h postoperatively to assess the effective analgesia by visual analog scale (VAS) score  1 year  
 
Secondary Outcome  
Outcome  TimePoints 
To assess and compare the hemodynamic changes.
To assess and compare the proportion of patients having adverse effect and other complication. 
Around 1 year  
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   13/07/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   none yet  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Aim of our study to assess the efficacy of transversus abdominis plane block (TAP) for post operative analgesia in patient under going lower segment ceasarean section under spinal anasthesia by creating a comparison between ropivacaine (0.25%) and bupivacain(0.25%). 
Close